Last edition
News about "Ambrx Biopharma"
Jubilant Pharmova Appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics
Jubilant Pharmova has announced the appointment of Daniel J. O’Connor as CEO of its proprietary novel drugs business, Jubilant Therapeutics Inc.
Ambrx Biopharma | 02/12/2025 | By Dineshwori | 110
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members